rs121964965
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 5P and 1B. PP3_StrongPP5BS2_Supporting
The NM_000071.3(CBS):c.415G>A(p.Gly139Arg) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000071.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000947 AC: 1AN: 105604Hom.: 0 Cov.: 15
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250444Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135554
GnomAD4 exome AF: 0.00000949 AC: 10AN: 1054038Hom.: 2 Cov.: 19 AF XY: 0.0000131 AC XY: 7AN XY: 534946
GnomAD4 genome AF: 0.00000947 AC: 1AN: 105640Hom.: 0 Cov.: 15 AF XY: 0.0000195 AC XY: 1AN XY: 51278
ClinVar
Submissions by phenotype
Homocystinuria, pyridoxine-responsive Pathogenic:1
- -
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 139 of the CBS protein (p.Gly139Arg). This variant is present in population databases (rs121964965, gnomAD 0.01%). This missense change has been observed in individual(s) with homocystinuria due to CBS deficiency (PMID: 7611293). ClinVar contains an entry for this variant (Variation ID: 121). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CBS protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CBS function (PMID: 22267502). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
not specified Uncertain:1
Variant summary: CBS c.415G>A (p.Gly139Arg) results in a non-conservative amino acid change located in the Tryptophan synthase beta chain-like, PALP domain (IPR001926) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 250444 control chromosomes (gnomAD). c.415G>A has been reported in the literature in at least one compound heterozygous individual affected with Homocystinuria (Shih_1995). These data do not allow any conclusion about variant significance. One publication using a yeast ortholog replacement assay reports experimental evidence indicating the variant has an intermediate phenotype that is responsive to B6 supplementation (Mayfield_2012). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at